Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STKL
4376
DELISTED
SunOpta
STKL
| $1.85M | ﹤0.01% |
203,328
+52,496
| +35% | +$498K |
|
4377
Nuveen Mortgage and Income Fund
JLS
$94.1M
| $1.85M | ﹤0.01% |
114,828
-9
| -0% | -$150 |
|
4378
ARKO Corp
ARKO
$544M
| $1.84M | ﹤0.01% |
196,509
-7,293
| -4% | -$69.2K |
|
4379
Civeo
CVEO
$344M
| $1.84M | ﹤0.01% |
73,433
-4,198
| -5% | -$114K |
|
4380
Sutro Biopharma
STRO
$340M
| $1.84M | ﹤0.01% |
33,157
-54
| -0.2% | -$3.2K |
|
4381
Rimini Street
RMNI
$466M
| $1.84M | ﹤0.01% |
394,308
-21,491
| -5% | -$121K |
|
4382
InflaRx
IFRX
$301M
| $1.84M | ﹤0.01% |
695,377
-73,355
| -10% | -$165K |
|
4383
McCormick & Company Voting
MKC.V
$14.6B
| $1.83M | ﹤0.01% |
25,005
-5
| -0% | -$418 |
|
|
TDAY
4384
USA Today Co
TDAY
$1.03B
| $1.83M | ﹤0.01% |
1,193,901
+70,557
| +6% | +$171K |
|
4385
Liquidia Corp
LQDA
$6.66B
| $1.82M | ﹤0.01% |
335,399
-68,212
| -17% | -$383K |
|
|
AXIA.PR
4386
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
| $1.82M | ﹤0.01% |
271,306
-318,890
| -54% | -$2.29M |
|
|
SPNS
4387
DELISTED
Sapiens International
SPNS
| $1.82M | ﹤0.01% |
94,816
+55,516
| +141% | +$1.26M |
|
4388
IDT Corp
IDT
$1.66B
| $1.82M | ﹤0.01% |
73,251
-14,874
| -17% | -$382K |
|
|
ACLX
4389
DELISTED
Arcellx
ACLX
| $1.81M | ﹤0.01% |
96,705
+19,562
| +25% | +$374K |
|
|
MVT
4390
DELISTED
BlackRock MuniVest Fund II
MVT
| $1.81M | ﹤0.01% |
179,938
-9,440
| -5% | -$107K |
|
4391
Universal Electronics
UEIC
$67.9M
| $1.81M | ﹤0.01% |
91,946
+10,026
| +12% | +$237K |
|
4392
Hartford Multifactor US Equity ETF
ROUS
$735M
| $1.8M | ﹤0.01% |
51,085
+25,687
| +101% | +$997K |
|
|
NXC
4393
DELISTED
Nuveen CA Select Tax-Free Income Portfolio
NXC
| $1.8M | ﹤0.01% |
137,831
+17,935
| +15% | +$245K |
|
|
SCU
4394
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $1.8M | ﹤0.01% |
204,003
+1,188
| +0.6% | +$11K |
|
|
PZC
4395
DELISTED
PIMCO California Municipal Income Fund III
PZC
| $1.79M | ﹤0.01% |
245,526
+1,311
| +0.5% | +$10.9K |
|
4396
Ranpak Holdings
PACK
$478M
| $1.79M | ﹤0.01% |
523,808
+42,155
| +9% | +$232K |
|
|
RPTX
4397
DELISTED
Repare Therapeutics
RPTX
| $1.79M | ﹤0.01% |
147,257
-434
| -0.3% | -$5.59K |
|
|
DHC
4398
Diversified Healthcare Trust
DHC
$2.03B
| $1.77M | ﹤0.01% |
1,789,361
-1,289,722
| -42% | -$2.07M |
|
|
PHX
4399
DELISTED
PHX Minerals
PHX
| $1.77M | ﹤0.01% |
546,471
+245,509
| +82% | +$791K |
|
4400
Rayonier Advanced Materials
RYAM
$570M
| $1.77M | ﹤0.01% |
562,262
+42,732
| +8% | +$171K |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.